BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

690 related articles for article (PubMed ID: 16112535)

  • 1. Non-enzymatic glutathione reactivity and in vitro toxicity: a non-animal approach to skin sensitization.
    Aptula AO; Patlewicz G; Roberts DW; Schultz TW
    Toxicol In Vitro; 2006 Mar; 20(2):239-47. PubMed ID: 16112535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel approach for classifying chemicals according to skin sensitizing potency by non-radioisotopic modification of the local lymph node assay.
    Takeyoshi M; Iida K; Shiraishi K; Hoshuyama S
    J Appl Toxicol; 2005; 25(2):129-34. PubMed ID: 15744759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the skin sensitization potency of eugenol and its dimers using a non-radioisotopic modification of the local lymph node assay.
    Takeyoshi M; Noda S; Yamazaki S; Kakishima H; Yamasaki K; Kimber I
    J Appl Toxicol; 2004; 24(1):77-81. PubMed ID: 14745850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative relationship between the local lymph node assay and human skin sensitization assays.
    Schneider K; Akkan Z
    Regul Toxicol Pharmacol; 2004 Jun; 39(3):245-55. PubMed ID: 15135206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental reactivity parameters for toxicity modeling: application to the acute aquatic toxicity of SN2 electrophiles to Tetrahymena pyriformis.
    Roberts DW; Schultz TW; Wolf EM; Aptula AO
    Chem Res Toxicol; 2010 Jan; 23(1):228-34. PubMed ID: 19928804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contact allergenic potency: correlation of human and local lymph node assay data.
    Gerberick GF; Robinson MK; Ryan CA; Dearman RJ; Kimber I; Basketter DA; Wright Z; Marks JG
    Am J Contact Dermat; 2001 Sep; 12(3):156-61. PubMed ID: 11526521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of an ex vivo local lymph node assay to assess contact hypersensitivity potential.
    Piccotti JR; Kawabata TT
    J Immunotoxicol; 2008 Jul; 5(3):271-7. PubMed ID: 18830887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a peptide reactivity assay for screening contact allergens.
    Gerberick GF; Vassallo JD; Bailey RE; Chaney JG; Morrall SW; Lepoittevin JP
    Toxicol Sci; 2004 Oct; 81(2):332-43. PubMed ID: 15254333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A chemical dataset for evaluation of alternative approaches to skin-sensitization testing.
    Gerberick GF; Ryan CA; Kern PS; Dearman RJ; Kimber I; Patlewicz GY; Basketter DA
    Contact Dermatitis; 2004 May; 50(5):274-88. PubMed ID: 15209809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of in vitro testing to identify an unexpected skin sensitizing impurity in a commercial product: a case study.
    Natsch A; Gfeller H; Emter R; Ellis G
    Toxicol In Vitro; 2010 Mar; 24(2):411-6. PubMed ID: 19883749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LC-MS-based characterization of the peptide reactivity of chemicals to improve the in vitro prediction of the skin sensitization potential.
    Natsch A; Gfeller H
    Toxicol Sci; 2008 Dec; 106(2):464-78. PubMed ID: 18791182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Read-across to rank skin sensitization potential: subcategories for the Michael acceptor domain.
    Schultz TW; Rogers K; Aptula AO
    Contact Dermatitis; 2009 Jan; 60(1):21-31. PubMed ID: 19125718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a new in vitro skin sensitization assay (Epidermal Sensitization Assay; EpiSensA) using reconstructed human epidermis.
    Saito K; Nukada Y; Takenouchi O; Miyazawa M; Sakaguchi H; Nishiyama N
    Toxicol In Vitro; 2013 Dec; 27(8):2213-24. PubMed ID: 23999411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility and limitations of a peptide reactivity assay to predict fragrance allergens in vitro.
    Natsch A; Gfeller H; Rothaupt M; Ellis G
    Toxicol In Vitro; 2007 Oct; 21(7):1220-6. PubMed ID: 17513083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local lymph node assay (LLNA) for detection of sensitization capacity of chemicals.
    Gerberick GF; Ryan CA; Dearman RJ; Kimber I
    Methods; 2007 Jan; 41(1):54-60. PubMed ID: 16938465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin sensitization potency of methyl methacrylate in the local lymph node assay: comparisons with guinea-pig data and human experience.
    Betts CJ; Dearman RJ; Heylings JR; Kimber I; Basketter DA
    Contact Dermatitis; 2006 Sep; 55(3):140-7. PubMed ID: 16918612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Filling the concept with data: integrating data from different in vitro and in silico assays on skin sensitizers to explore the battery approach for animal-free skin sensitization testing.
    Natsch A; Emter R; Ellis G
    Toxicol Sci; 2009 Jan; 107(1):106-21. PubMed ID: 18832184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of chemical peptide reactivity for screening contact allergens: a classification tree model approach.
    Gerberick GF; Vassallo JD; Foertsch LM; Price BB; Chaney JG; Lepoittevin JP
    Toxicol Sci; 2007 Jun; 97(2):417-27. PubMed ID: 17400584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive identification of human skin sensitization thresholds.
    Basketter DA; Clapp C; Jefferies D; Safford B; Ryan CA; Gerberick F; Dearman RJ; Kimber I
    Contact Dermatitis; 2005 Nov; 53(5):260-7. PubMed ID: 16283904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of reactivity schemes for the prediction skin sensitization potential.
    Patlewicz G; Roberts DW; Uriarte E
    Chem Res Toxicol; 2008 Feb; 21(2):521-41. PubMed ID: 18189364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.